Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 12 (3), 191-204

The Placebo Response in Medicine: Minimize, Maximize or Personalize?

Affiliations
Review

The Placebo Response in Medicine: Minimize, Maximize or Personalize?

Paul Enck et al. Nat Rev Drug Discov.

Abstract

Our understanding of the mechanisms mediating or moderating the placebo response to medicines has grown substantially over the past decade and offers the opportunity to capitalize on its benefits in future drug development as well as in clinical practice. In this article, we discuss three strategies that could be used to modulate the placebo response, depending on which stage of the drug development process they are applied. In clinical trials the placebo effect should be minimized to optimize drug-placebo differences, thus ensuring that the efficacy of the investigational drug can be truly evaluated. Once the drug is approved and in clinical use, placebo effects should be maximized by harnessing patients' expectations and learning mechanisms to improve treatment outcomes. Finally, personalizing placebo responses - which involves considering an individual's genetic predisposition, personality, past medical history and treatment experience - could also maximize therapeutic outcomes.

Similar articles

See all similar articles

Cited by 129 PubMed Central articles

See all "Cited by" articles

References

    1. Clin J Pain. 2012 Jun;28(5):437-51 - PubMed
    1. JAMA. 2008 Mar 5;299(9):1016-7 - PubMed
    1. J Neurosci. 2006 Apr 19;26(16):4437-43 - PubMed
    1. Brain Behav Immun. 2011 Oct;25(7):1444-51 - PubMed
    1. Psychother Psychosom. 2008;77(4):227-34 - PubMed

Publication types

LinkOut - more resources

Feedback